ALLK Insider Trading

Insider Ownership Percentage: 16.12%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $87,934.64

Allakos Insider Trading History Chart

This chart shows the insider buying and selling history at Allakos by year and by quarter.

Skip ChartChart Data in Insider Trading History Table
2022202320242025$0bought$0soldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$10M$0$10MTotal Insider BuyingTotal Insider Selling

Allakos Share Price & Price History

Current Price: $0.23
Price Change: Price Decrease of -0.0046 (-1.96%)
As of 03/28/2025 05:00 PM ET

This chart shows the closing price history over time for ALLK up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
MayJunJulAugSepOctNovDecJanFebMar$0.23Closing price on 03/29/25:

Allakos Insider Trading History

See Full Table

SEC Filings (Institutional Ownership Changes) for Allakos (NASDAQ:ALLK)

84.64% of Allakos stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at ALLK by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table
2022202320242025$2.44Mbought$365ksoldQ1Q2Q3Q4Q1Q2Q3Q4Q1Q2Q3Q4Q1-$4M-$2M$0$2M$4MTotal InflowsTotal Outflows
Allakos logo
Allakos Inc., a clinical stage biotechnology company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases in the United States. The company's lead product candidate is AK006, which in a Phase I clinical trial for the treatment of chronic spontaneous urticaria (CSU) and other indications. The company was incorporated in 2012 and is headquartered in San Carlos, California.
Read More on Allakos

Today's Range

Now: $0.23
Low: $0.22
High: $0.24

50 Day Range

MA: $0.34
Low: $0.23
High: $1.21

52 Week Range

Now: $0.23
Low: $0.22
High: $1.56

Volume

734,744 shs

Average Volume

1,003,535 shs

Market Capitalization

$20.76 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.72

Who are the company insiders with the largest holdings of Allakos?

Allakos' top insider investors include:
  1. Harlan Baird Radford (CFO)
Learn More about top insider investors at Allakos.

Who are the major institutional investors of Allakos?

Allakos' top institutional shareholders include:
  1. Deep Track Capital LP — 6.38%
  2. Lynx1 Capital Management LP — 4.06%
  3. Point72 Asset Management L.P. — 4.02%
  4. Redmile Group LLC — 3.37%
  5. Alta Partners Management Company L.P. — 2.85%
  6. RA Capital Management L.P. — 1.26%
Learn More about top institutional investors of Allakos stock.

Which major investors are selling Allakos stock?

Within the last quarter, ALLK stock was sold by these institutional investors:
  1. Millennium Management LLC
  2. Deutsche Bank AG
  3. Platinum Investment Management Ltd.
  4. Bank of America Corp DE
  5. RBF Capital LLC
  6. Barclays PLC
  7. Rock Springs Capital Management LP
  8. Redmile Group LLC

Which major investors are buying Allakos stock?

In the last quarter, ALLK stock was purchased by institutional investors including:
  1. Lynx1 Capital Management LP
  2. Alta Partners Management Company L.P.
  3. Point72 Asset Management L.P.
  4. RA Capital Management L.P.
  5. Deep Track Capital LP
  6. Tang Capital Management LLC
  7. OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC
  8. Renaissance Technologies LLC